Outcomes of patients who underwent treatment for anti‐HLA donor‐specific antibodies before receiving a haploidentical hematopoietic cell transplant-Reference-Cited by-同舟云学术

Outcomes of patients who underwent treatment for anti‐HLA donor‐specific antibodies before receiving a haploidentical hematopoietic cell transplant

Published:2022-09-21 Issue:12 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Lipsitt Amanda¹,Arnold Paula²^ORCID,Chi Liying²,Carruthers Katharine¹,Folk Sophia¹,Fossey Sallyanne³,Keerthi Dinesh¹,Mamcarz Ewelina¹,Srinivasan Ashok¹,Sharma Akshay¹^ORCID

Affiliation:

1. Department of Bone Marrow Transplantation and Cellular Therapy St. Jude Children's Research Hospital Memphis Tennessee USA

2. Department of Pathology St. Jude Children's Research Hospital Memphis Tennessee USA

3. Transplant Immunology Laboratory Dialysis Clinic Inc Nashville Tennessee USA

Funder

American Society of Hematology

American Lebanese Syrian Associated Charities

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29993

Reference12 articles.

1. The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation

2. Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT

3. Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets

4. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation

5. Treatment of allosensitized patients receiving allogeneic transplantation

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor‐specific antibody prior to haploidentical transplantation;Pediatric Blood & Cancer;2024-09-03

2. Daratumumab treatment in six highly sensitised solid organ transplant recipients: A case series and literature review;HLA;2024-04

3. Donor‐specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report;British Journal of Haematology;2024-01-11

4. A Single Centre Experience of Effective Desensitization Strategy for Children with High Anti-HLA Donor-Specific Antibodies Undergoing Haploidentical Hematopoietic Stem Cell Transplantation;Indian Journal of Hematology and Blood Transfusion;2023-06-20

5. Bortezomib;Reactions Weekly;2023-03-25